In a trachoma hyperendemic region, a TF prevalence <5% was successfully maintained in five districts for ≥2 years after stopping MDA. MDA is still not warranted for these districts, however, the S, F and E components of the SAFE strategy should continue.
This joint open letter issued by six leading eye health agencies calls on Commonwealth leaders to commit to bringing eye care to all
This article was originally published in the Community Eye Health Journal Vol. 30 No. 100
This case study was originally published by Uniting to Combat NTDs
This study assesses the reliability of measuring a clean face and suggests assessment of clean faces could be added to trachoma surveys.
The WHO Alliance for the Global Elimination of Blinding Trachoma by the year 2020 progress report on elimination in 2016.
Contributions to this special issue underscore the impression that the Alliance for the Global Elimination of Trachoma by 2020 is on track for success as well as highlighting a few areas where further focused, thoughtful research is required.
This briefing was originally found in Eliminating Trachoma: Accelerating Towards 2020.